VITROS® MicroSlide Assay Summary Pub. No.

J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Serum 10 9 TDM PV Specialty Diluent 10–200 μg/mL Therapeutic: 670 2 ≤5 weeks Frozen
ACET
− Heparin 66–1323 μmol/L 10–30 μg/mL 66–199 μmol/L
Acetaminophen FS Diluent Pack 3
plasma (μmol/L = μg/mL x 6.616) Possible Toxicity:
− EDTA plasma 150 –200 μg/mL 992–1323 μmol/L
Probable Toxicity:
> 200 μg/mL > 1323 μmol/L
ALB − Serum 5.5 4 PV Isotonic saline or 1.00–6.00 g/dL 3.5–5.0 g/dL 35–50 g/L 630 1 ≤1 week Frozen or Refrigerated
− Heparin Reagent-grade water 10.0-60.0 g/L
Albumin plasma (g/L = g/dL x 10)

ALC − Serum 10 8 Liquid PV 7% BSA 10–300 mg/dL Negative: 340 2 ≤1 week Frozen
− Heparin 2.2–65.1 mmol/L <10 mg/dL <2 mmol/L
Alcohol plasma FS Diluent Pack 2
(mmol/L = mg/dL x 0.217) Toxic:
− Fluoride 50–100 mg/dL 11–22 mmol/L
Oxalate Depression of CNS:
plasma
>100 mg/dL >22 mmol/L
Fatalities
Reported:
>400 mg/dL >87 mmol/L
− Serum 11 3 PV 7% BSA 20–1500 U/L 38–126 U/L 400 2 ≤2 weeks Frozen or Refrigerated
ALKP
− Heparin
Alkaline plasma FS Diluent Pack 2
Phosphatase

ALT − Serum 11 3 PV 7% BSA 6–1000 U/L Adult: 13–69 U/L 340 2 ≤ 4 weeks Frozen or Refrigerated
− Heparin FS Diluent Pack 2 Female: 9–52 U/L
Alanine plasma Male: 21–72 U/L
Aminotransferase − EDTA plasma
− Serum 7 3 PV 7% BSA 4-750 U/L Female: <35 U/L 670 2 ≤ 2 weeks Frozen or
ALTV
− Heparin FS Diluent Pack 2 Male: <50 U/L Refrigerated ≤ 3 months
Alanine plasma
Aminotransferase
− Heparin 10 5 Liquid PV Reagent-grade water 8.7–500.0 μmol/L 9–30 μmol/L 600 2 ≤ 1 week Frozen
AMON
plasma FS Diluent Pack 3
Ammonia − EDTA plasma

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 1
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
AMYL − Serum 10 3 PV Specialty Diluent or 30–1200 U/L Adult: 30–110 U/L 540 1 ≤ 2 weeks Frozen or
− Heparin low patient sample Refrigerated ≤ 4 weeks
Amylase plasma
FS Diluent Pack 3
− Urine Isotonic saline 30–1200 U/L 32–641 U/L
FS Diluent Pack 2
− Serum 7 3 PV 7% BSA 3.0–750.0 U/L Adult: 15–46 U/L 670 2 ≤ 2 weeks Frozen or
AST
− Heparin FS Diluent Pack 2 Female: 14–36 U/L Refrigerated ≤ 3 months
Aspartate plasma
Aminotransferase Male: 17–59 U/L
BuBc − Serum 10 4 PV 7% BSA or normal Bu: 0.0–27.0 mg/dL Adult: 400 1 ≤ 2 weeks Frozen or Refrigerated
− Heparin patient sample 0–462 μmol/L Bu: 0.0–1.1 mg/dL 0–19 μmol/L &
Bilirubin, plasma FS Diluent Pack 2 Bc: 0.0–27.0 mg/dL Bc: 0.0–0.3 mg/dL 0–5 μmol/L 460
unconjugated and
0–462 μmol/L Neonate:
conjugated
(μmol/L = mg/dL x 17.1) Bu: 0.6–10.5 mg/dL 10–180 μmol/L
Bc: 0.0–0.6 mg/dL 0–10 μmol/L
− Serum 5.5 1 PV 7% BSA 2.0–120.0 mg/dL (urea N) Male: 670 1 ≤ 2 weeks Frozen or Refrigerated
BUN/UREA
− Heparin FS Diluent Pack 2 0.71–42.83 mmol/L (urea) 9–20 mg/dL (urea N) 3.2–7.1 mmol/L (urea)
Blood Urea plasma (mmol/L = mg/dL x 0.3569)
Nitrogen − EDTA plasma Female:
7–17 mg/dL (urea N) 2.5–6.1 mmol/L (urea)
1
− Urine (diluted) Isotonic saline or 67–2520 mg/dL (urea N) 24 Hour:
Reagent-grade water1 23.91–899.39 mmol/L (urea) 12–20 g/day 428–714 mmol/day
FS Diluent Pack 3 after x21 dilution with water (urea N) (urea)
(mmol/L = mg/dL x 0.3569)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 2
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
1
Ca − Serum 10 1 PV Isotonic saline or 1.00–14.00 mg/dL 8.4–10.2 mg/dL 2.10–2.55 mmol/L 680 1 ≤ 4 weeks Frozen or Refrigerated
1
− Heparin Reagent-grade water 0.25–3.49 mmol/L
Calcium plasma FS Diluent Pack 2 or (mmol/L = mg/dL x 0.2495)
FS Diluent Pack 3

− Urine Reagent-grade water1 1.00–17.80 mg/dL Ca-free:

(pretreated) FS Diluent Pack 3 0.25–4.44 mmol/L 5–40 mg/day 0.13–1.00 mmol/day
(mmol/L = mg/dL x 0.2495)
Low to Average:
50–150 mg/day 1.25–3.75 mmol/day

Average:
100–300 mg/day 2.50–7.50 mmol/day
CHE − Serum 11 6 PV 7% BSA 0.20–12.50 U/mL Male: 400 2 ≤4 weeks Frozen
− Heparin FS Diluent Pack 2 200–12500 U/L 5.90–12.22 U/mL 5900–12220 U/L
Cholinesterase 2
plasma (U/L = U/mL x 1000) Female:
4.65–10.44 U/mL 4650–10440 U/L
− Serum 5.5 2 PV 7% BSA 50–325 mg/dL Desirable: 540 1 ≤2 weeks Frozen or
CHOL
− Heparin FS Diluent Pack 2 1.29–8.40 mmol/L <200 mg/dL <5.2 mmol/L Refrigerated ≤ 6 months
Cholesterol plasma (mmol/L = mg/dL x 0.02586) Borderline High:
200–239 mg/dL 5.2–6.2 mmol/L
High:
≥240 mg/dL 6.2 mmol/L
− Serum 11 3 PV or 7% BSA 20–1600 U/L Female: 30–135 U/L 670 2 ≤1 week Frozen or
CK
− Heparin Iso- FS Diluent Pack 2 Male: 55–170 U/L Refrigerated ≤ 4 weeks
Creatine Kinase plasma enzyme
PV
CKMB – Serum 11 6 Iso- 7% BSA 2.7–300.0 U/L Refer to the CKMB Instructions for Use sheet 670 2 ≤1 week Frozen
enzyme FS Diluent Pack 2
Creatine
PV
Kinase MB

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 3
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
Cl- − Serum 10 2 PV Do not dilute 50.0–175.0 mmol/L Adult: 98–107 mmol/L N/A 1 ≤2 weeks Frozen or Refrigerated
Chloride − Heparin
plasma
− Urine N/A 15–300 mmol/L Urine (Random): 18–209 mmol/L
Urine (24-Hour): 110–250 mmol/Day
− Serum 11 9 TDM PV Do not dilute 3.0–20.0 μg/mL Therapeutic Range: 670 1 ≤1 week Frozen
CRBM
− Heparin 12.7–84.6 μmol/L 4.0–12.0 μg/mL 16.9–50.8 μmol/L
Carbamazepine plasma (μmol/L = μg/mL x 4.23)
− Serum 6 1 PV 7% BSA 0.15–14.0 mg/dL Male: 670 2 ≤2 weeks Frozen or
CREA
− Heparin FS Diluent Pack 2 13–1238 μmol/L 0.66–1.25 mg/dL 58–110 μmol/L Refrigerated ≤4 weeks
Creatinine plasma (μmol/L = mg/dL x 88.4) Female:
0.52–1.04 mg/dL 46–92 μmol/L
− Urine (diluted) Reagent-grade water1 3.2–346.5 mg/dL 24 Hour
FS Diluent Pack 3 283–30631 μmol/L Male:
after x21 dilution with water 1000–2000 mg/day 8840–17680 μmol/day
(μmol/L = mg/dL x 88.4 ) Female:
800–1800 mg/day 7072–15912 μmol/day
− Serum 11 7 CRP PV Specialty Diluent or 5–90 mg/L <10 mg/L <1.0 mg/dL 670 1 ≤48 hours Frozen
CRP
− Heparin low patient sample 0.5–9.0 mg/dL
C-Reactive plasma FS Diluent Pack 3 (mg/dL = mg/L / 10)
Protein − EDTA plasma
− Serum 11 9 PV 7% BSA 0.40–4.00 ng/mL Therapeutic Range: 670 1 ≤1 week Frozen
DGXN
or FS Diluent Pack 2 0.51–5.12 nmol/L 0.8–2.0 ng/mL 1.0–2.6 nmol/L
Digoxin
TDM PV (nmol/L = ng/mL x 1.28)
− Serum 10 25 PV 7% BSA 5.0–110.0 mg/dL Low: 670 1 ≤7 days Frozen or
dHDL
− Heparin 0.13–2.84 mmol/L <40.0 mg/dL <1.03 mmol/L Refrigerated ≤12 weeks
Direct HDL plasma FS Diluent Pack 2
(mmol/L = mg/dL x 0.02586) High:
Cholesterol
≥60.0 mg/dL ≥1.55 mmol/L
− Serum 6 25 PV 7% BSA 5.0–110.0 mg/dL Low: 670 1 ≤7 days Frozen or
dHDL
− Heparin 0.13–2.84 mmol/L <40.0 mg/dL <1.03 mmol/L Refrigerated ≤12 weeks
Direct HDL plasma FS Diluent Pack 2
(mmol/L = mg/dL x 0.02586) High:
Cholesterol
(3200+) ≥60.0 mg/dL ≥1.55 mmol/L

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 4
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
ECO2 − Serum 6 2 PV Isotonic Saline 5.0–40.0 mmol/L 22–30 mmol/L 340 2 ≤4 weeks Frozen or Refrigerated
− Heparin FS Diluent Pack 2
Carbon Dioxide plasma
− Serum 10 4 PV Iron-free reagent- 10.1–600.0 μg/dL Female: 600 2 ≤4 weeks Frozen
Fe
− Heparin grade water 1.81–107.46 μmol/L 37–170 μg/dL 6.6–30.4 μmol/L
Iron plasma FS Diluent Pack 3 (μmol/L = μg/dL x 0.1791) Male:
49–181 μg/dL 8.8–32.4 μmol/L
− Serum 11 3 PV 7% BSA 10–1400 U/L Adult: 12–58 U/L 400 2 ≤4weeks Frozen or Refrigerated
GGT
− Heparin FS Diluent Pack 2 Female: 12–43 U/L
Gamma plasma
Glutamyltrans- ferase − EDTA plasma Male: 15–73 U/L
− Serum 10 1 PV 7% BSA 20.0–625.0 mg/dL Fasting Adult: 540 2 ≤1week Frozen or Refrigerated
GLU
− Heparin FS Diluent Pack 2 1.11–34.69 mmol/L 74–106 mg/dL 4.1–5.9 mmol/L
Glucose plasma (mmol/L = mg/dL x 0.05551) IMPORTANT
− EDTA plasma When using sodium
− Sodium fluroride/potassium
Fluoride/ oxalate specimen type:
Potassium
Refrigerated ≤4 months
oxalate
plasma
− Urine Isotonic saline or 20.0–650.0 mg/dL 24 Hour:
Reagent-grade water 1.11–36.08 mmol/L <500 mg/day <2.8 mmol/day
FS Diluent Pack 2 or (mmol/L = mg/dL x 0.05551) Random:
FS Diluent Pack 3 <30 mg/dL <1.7 mmol/L

− CSF2 Liquid 20.0–650.0 mg/dL 40–70 mg/dL 2.2–3.9 mmol/L

PV 1.11–36.08 mmol/L
(mmol/L = mg/dL x 0.05551)
− Serum 10 2 PV Do not dilute 1.00–14.00 mmol/L Serum: 3.5–5.1 mmol/L N/A 1 ≤2 weeks Frozen or Refrigerated
K+
− Heparin Plasma: 0.1–0.7 mmol/L lower
2
plasma than serum range
− Urine (diluted) Liquid PV Reagent-grade water1 2.50–175.00 mmol/L 24 Hour: 25.0–125.0 mmol/day
FS Diluent Pack 1 after x5 dilution with UED (diet dependent)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 5
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
LAC − Heparin 10 1 PV Isotonic saline or 0.50–12.00 mmol/L 0.7–2.1 mmol/L 540 2 ≤2 weeks Frozen
plasma Reagent-grade water
Lactate (keep whole
blood on FS Diluent Pack 2 or
ice) FS Diluent Pack 3
− Fluoride
oxalate
plasma
− Serum 11 3 PV 7% BSA 100–2150 U/L 313–618 U/L 340 2 ≤2 weeks Frozen or
LDH
− Heparin FS Diluent Pack 2 Refrigerated ≤4 weeks
Lactate plasma
Dehydrogenase
LDHI − Serum 11 3 PV 7% BSA 41–1000 U/L 120–246 U/L 340 2 ≤2 weeks Frozen or
− Heparin FS Diluent Pack 2 Refrigerated ≤4 weeks
Lactate plasma
Dehydrogenase
− Serum 10 1 PV 7% BSA 0.20–4.00 mmol/L Therapeutic: 0.6–1.2 mmol/L 600 2 ≤5 weeks Frozen
Li
− Heparin FS Diluent Pack 2 Potentially Toxic: >1.5 mmol/L
Lithium plasma
− EDTA plasma Severely Toxic: >2.5 mmol/L

LIPA − Serum 5.5 3 PV 7% BSA 10–2000 U/L 23–300 U/L 540 1 ≤1 week Frozen
− Heparin FS Diluent Pack 2
Lipase plasma
− Serum 5 1 PV Isotonic saline or 0.20–10.0 mg/dL 1.6–2.3 mg/dL 0.7–1.0 mmol/L 630 1 ≤2 weeks Frozen
Mg
− Heparin Reagent-grade water 0.08–4.11 mmol/L
Magnesium plasma FS Diluent Pack 2 or (mmol/L = mg/dL x 0.4114)
FS Diluent Pack 3
− Urine Reagent-grade water 1.20–60.0 mg/dL 24 Hour:
(pretreated, FS Diluent Pack 3 0.49–24.68 mmol/L 73.0–122.0 mg/day 3.0–5.0 mmol/day
diluted) after x6 dilution with water
(mmol/L = mg/dL x 0.4114)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 6
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
Na+ − Serum 10 2 PV Do not dilute 75.0–250.0 mmol/L 137–145 mmol/L N/A 1 ≤10 days Frozen or
− Heparin Refrigerated ≤3 months
4
Sodium plasma
− Urine (diluted) Liquid PV Reagent-grade water 5.0–250.0 mmol/L 24 Hour: 40–220 mmol/day
after x5 dilution with Random: 30–90 mmol/L
FS Diluent Pack 1
UED
PHOS − Serum 10 1 PV Isotonic saline or 0.50–13.00 mg/dL 2.5–4.5 mg/dL 0.81–1.45 mmol/L 680 1 ≤4 weeks Frozen or Refrigerated
− Heparin Reagent-grade water 0.16–4.20 mmol/L or
Phosphorous plasma 670
FS Diluent Pack 2 or (mmol/L = mg/dL x 0.3229)
FS Diluent Pack 3
1
− Urine Reagent-grade water 5.50–143.00 mg/dL 24 hour:
(pretreated, FS Diluent Pack 3 1.78–46.17 mmol/L 0.4–1.3 g/day 12.9–42.0 mmol/day
diluted) after x11 dilution with water
(mmol/L = mg/dL x 0.3229)
PHYT − Serum 11 9 PV or 7% BSA 3.00–40.00 μg/mL Therapeutic Range: 670 1 ≤1 week Frozen
− Heparin TDM PV FS Diluent Pack 2 11.88–158.40 μmol/L 10.0–20.0 μg/mL 39.6–79.2 μmol/L
Phenytoin plasma (μmol/L = μg/mL x 3.96)
PROT − CSF 10 5 Liquid PV Isotonic saline 10–300 mg/dL CSF: 670 2 ≤1 week Frozen
FS Diluent Pack 2 100–3000 mg/L 12–60 mg/dL 120–600 mg/L
Cerebrospinal Fluid
(mg/L = mg/dL x 10)
Protein
− Serum 10 1 Liquid PV 7% BSA 1.0–40.0 mg/dL Negative: 540 2 ≤5 weeks Frozen
SALI
− Heparin FS Diluent Pack 2 0.07–2.90 mmol/L <2 mg/dL <0.1 mmol/L
Salicylate plasma (mmol/L = mg/dL x 0.0724) Therapeutic:
<20 mg/dL <1.5 mmol/L
Toxic:
>30 mg/dL >2.2 mmol/L
Lethal:
>60 mg/dL >4.3 mmol/L
TBIL − Serum 10 4 PV Reagent-grade water 0.10–27.00 mg/dL 0.2–1.3 mg/dL 3–22 μmol/L 540 1 ≤2 weeks Frozen or Refrigerated
− Heparin FS Diluent Pack 3 1.7–461.7 μmol/L &
Total Bilirubin plasma (μmol/L = mg/dL x 17.1) 460

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 7
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
THEO − Serum 10 1 PV 7% BSA 1.00–40.00 μg/mL 10.0–20.0 μg/mL 55.5–111.0 μmol/L 400 2 ≤1 week Frozen
− Heparin FS Diluent Pack 2 5.55–222.00 μmol/L
Theophylline plasma (μmol/L = μg/mL x 5.55)

− Serum (pre- 10 4 PV Iron-free deionized 85–650 μg/dL Male: 600 Refer to ‘Fe’ on page 5
TIBC
treated) Water1 15.2–116.4 μmol/L 261–462 μg/dL 46.8–82.7 μmol/L
Total Iron-Binding
(μmol/L = μg/dL x 0.1791) Female:
Capacity
265–497 μg/dL 47.4–89.0 μmol/L

TP − Serum 10 4 PV Isotonic saline or 2.00–11.00 g/dL 6.3–8.2 g/dL 63–82 g/L 540 1 ≤4 weeks Frozen or Refrigerated
− Heparin Reagent-grade water 20.0–110.0 g/L
Total Protein plasma FS Diluent Pack 2 or (g/L = g/dL x 10.0)
FS Diluent Pack 3

− Serum 6.5 4 PV Isotonic saline or 2.00–11.00 g/dL 6.3–8.2 g/dL 63–82 g/L 540 1 ≤4 weeks Frozen or Refrigerated
TP
− Heparin Reagent-grade water 20.0–110.0 g/L
Total Protein plasma FS Diluent Pack 2 or (g/L = g/dL x 10.0)
(3200+)
FS Diluent Pack 3

− Serum 5.5 2 PV 7% BSA 10.0–525.0 mg/dL Normal: 540 1 ≤1 week Frozen

TRIG
− Heparin FS Diluent Pack 2 0.11–5.93 mmol/L <150 mg/dL <1.69 mmol/L
Triglyceride plasma (mmol/L = mg/dL x 0.01129) Borderline High:
150–199 mg/dL 1.69–2.25 mmol/L
High:
200–499 mg/dL 2.26–5.64 mmol/L
Very High:
≥500 mg/dL ≥5.65 mmol/L

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 8
 VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Reaction Sample

Recommended

Slide Supply

On-Analyzer
Volume (µL)
Specimens2

Filter (nm)
Calibrator
Suggested Reference Interval or

Stability
Control

Diluent
Measuring Cutoff
Test Name/ (Reportable or Dynamic) Refer to the Instructions for Use for Long-term Reagent
Abbreviation Range further Interpretation of Results Storage3
− Urine 10 10 UPRO PV Reagent-grade water1 5–200 mg/dL Random: 670 1 ≤2 weeks Frozen
UPRO
FS Diluent Pack 3 0.05–2.00 g/L <12 mg/dL <0.12 g/L
Urine Protein
(g/L = mg/dL x 0.01) 24 Hour:
42–225 mg/day 0.04–0.23 g/day

− Serum 10 1 PV 7% BSA 0.50–17.00 mg/dL Male: 670 1 ≤2 weeks Frozen or Refrigerated

URIC
− Heparin FS Diluent Pack 2 29.7–1011.2 μmol/L 3.5–8.5 mg/dL 208–506 μmol/L
Uric Acid plasma (μmol/L = mg/dL x 59.48) Female:
2.5–6.2 mg/dL 149–369 μmol/L
− Urine Reagent-grade water1 5.50–187.00 mg/dL 24 Hour:
(pretreated, FS Diluent Pack 3 327.1–11122.8 μmol/L 250–750 mg/day 1480–4430 μmol/day
diluted) after x11 dilution with water
(μmol/L = mg/dL x 59.48)

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 9
VITROS® MicroSlide Assay Summary Pub. No. J23323_EN
2018-07-03

Derived Tests
Test Calculation Test Calculation
A/G Albumin/Globulin Ratio Alb / (TP - ALB) GLOB Globulin TP - ALB
Conv. Units: (CHOL - HDLC) - ( TRIG/5)
AGp Anion Gap without K+ (Na+) - (Cl- + ECO2) LDL Low Density Lipoprotein
SI Units: (CHOL - HDLC) - ( TRIG/2.2)
Anion Gap + + -
AGpK + (Na + K ) - (Cl + ECO2) NBil Neonatal Bilirubin Bu + Bc
with K
B/CR BUN/Creatinine Ratio BUN / CREA OSMO Osmolality (Na+ x 1.86) + (GLU/18) + (BUN/2.8)
Conv. Units: TRIG/5
C/H Cholesterol/HDLC Ratio CHOL / HDLC VLDL Very Low Density Lipoprotein
SI Units: TRIG /2.2
(CKMB/CK) x 100
DBIL Direct Bilirubin TBIL - Bu % MB CKMB/CK Ratio

(Fe/TIBC) x 100
DELB Delta Bilirubin TBIL - (Bu + Bc) % Sat Percent Iron Saturation

This information was current as of the publication date. The Instructions for Use are the authorized source for information about VITROS Chemistry Products. Not all products and systems are available in all countries.

1
See Instructions for Use for the special dilution procedure.
2
See Instructions for Use for specimen Interferent information.
3
Minimum warm-up time to room temperature is 60 minutes if frozen and 30 minutes if refrigerated.
4
Minimum warm-up time for Na+ is 120 minutes if frozen and 90 minutes if refrigerated.

© Ortho-Clinical Diagnostics, Inc., 2018 • VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. • 100 Indigo Creek Drive • Rochester, NY 14626 10